Skip to content
  • Sunday, 26 July 2026
  • 2:56 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • A New Two-Component Dark Matter Model Explains the Galactic Center Gamma-Ray Excess While Reconciling the Absence of Signals in Dwarf Galaxies
Advanced Materials Science

A New Two-Component Dark Matter Model Explains the Galactic Center Gamma-Ray Excess While Reconciling the Absence of Signals in Dwarf Galaxies

Nila Kartika Wati May 4, 2026 0

The search for dark matter, the invisible substance believed to constitute approximately 85% of the matter in the universe, has…

Read More
Advanced Materials Science

The Invisible Conflict Two-Component Dark Matter Model Explains Discrepancy Between Milky Way Gamma-Ray Excess and Dwarf Galaxy Observations

Nila Kartika Wati Apr 26, 2026 0

The pursuit of dark matter, the elusive substance believed to constitute approximately 85 percent of the universe’s total matter, has…

Read More
Advanced Materials Science

The Galactic Center Excess and the Mystery of Two-Component Dark Matter: New Research Explains the Silence of Dwarf Galaxies

Nila Kartika Wati Apr 18, 2026 0

The pursuit of dark matter remains one of the most profound challenges in modern astrophysics, as this invisible substance is…

Read More
Advanced Materials Science

Two-Component Dark Matter Models and the Galactic Center Gamma-Ray Excess: Reconciling the Silence of Dwarf Galaxies

Nila Kartika Wati Apr 11, 2026 0

The pursuit of dark matter remains one of the most formidable challenges in modern astrophysics, as this elusive substance constitutes…

Read More
Local Agentic Programming on the Cheap: Claude Code + Ollama + Gemma4Cal Poly Physics Researchers Unveil Flux-Switching Floquet Engineering to Create Stable New Quantum States for Future Computing ApplicationsScience News: A Century of Empowering Public Understanding of Science, Medicine, and TechnologyNucleai and Sirona Dx Forge Strategic Alliance to Revolutionize Spatial Proteomics for Drug Development
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ